Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains

Journal of Neuroimmunology

Volumn 237, Issue 1-2, 2011, Pages 73-79

  Zhang, Zhiren ^a,b   Zhang, Zhi Yuan ^b   Schittenhelm, Jens ^b   Wu, Yuzhang ^a   Meyermann, Richard ^b   Schluesener, Hermann J ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

CD163; Macrophages; Multiple sclerosis; Myelin

Indexed keywords

CD163 ANTIGEN; HLA DR ANTIGEN; LIPOPOLYSACCHARIDE; MYELIN; MYELIN BASIC PROTEIN;

ADULT; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BIOACCUMULATION; BRAIN TISSUE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; INFLAMMATORY CELL; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRAIN; CELL LINE, TRANSFORMED; HUMANS; IMMUNOPHENOTYPING; INFLAMMATION; MACROPHAGES; MICE; MICROGLIA; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RECEPTORS, CELL SURFACE;

EID: 80051471235     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.06.006     Document Type: Article

References (40)

1. Abraham N.G., Drummond G. CD163-Mediated hemoglobin-heme uptake activates macrophage HO-1, providing an antiinflammatory function. Circ. Res. 2006, 99:911-914.
2. Benoit M., Desnues B., Mege J.L. Macrophage polarization in bacterial infections. J. Immunol. 2008, 181:3733-3739.
3. Borda J.T., Alvarez X., Mohan M., Hasegawa A., Bernardino A., Jean S., Aye P., Lackner A.A. CD163, a marker of perivascular macrophages, is up-regulated by microglia in simian immunodeficiency virus encephalitis after haptoglobin-hemoglobin complex stimulation and is suggestive of breakdown of the blood-brain barrier. Am. J. Pathol. 2008, 172:725-737.
4. Bover L.C., Cardo-Vila M., Kuniyasu A., Sun J., Rangel R., Takeya M., Aggarwal B.B., Arap W., Pasqualini R. A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications. J. Immunol. 2007, 178:8183-8194.
5. Breij E.C., Brink B.P., Veerhuis R., van den Berg C., Vloet R., Yan R., Dijkstra C.D., van der Valk P., Bo L. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann. Neurol. 2008, 63:16-25.
6. Buechler C., Ritter M., Orso E., Langmann T., Klucken J., Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J. Leukoc. Biol. 2000, 67:97-103.
7. Cosenza M.A., Zhao M.L., Si Q., Lee S.C. Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol. 2002, 12:442-455.
8. Desplat-Jego S., Feuillet L., Creidy R., Malikova I., Rance R., Khrestchatisky M., Hahm K., Burkly L.C., Pelletier J., Boucraut J. TWEAK is expressed at the cell surface of monocytes during multiple sclerosis. J. Leukoc. Biol. 2009, 85:132-135.
9. Fabriek B.O., Van Haastert E.S., Galea I., Polfliet M.M., Dopp E.D., Van Den Heuvel M.M., Van Den Berg T.K., De Groot C.J., Van Der Valk P., Dijkstra C.D. CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation. Glia 2005, 51:297-305.
10. Gandhi R., Laroni A., Weiner H.L. Role of the innate immune system in the pathogenesis of multiple sclerosis. J. Neuroimmunol. 2010, 221:7-14.
11. Guillemin G.J., Brew B.J. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J. Leukoc. Biol. 2004, 75:388-397.
12. Hu W., Lucchinetti C.F. The pathological spectrum of CNS inflammatory demyelinating diseases. Semin. Immunopathol. 2009, 31:439-453.
13. Hulshof S., Montagne L., De Groot C.J., Van Der Valk P. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions. Glia 2002, 38:24-35.
14. Kim W.K., Alvarez X., Fisher J., Bronfin B., Westmoreland S., McLaurin J., Williams K. CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. Am. J. Pathol. 2006, 168:822-834.
15. Komohara Y., Hirahara J., Horikawa T., Kawamura K., Kiyota E., Sakashita N., Araki N., Takeya M. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype. J. Histochem. Cytochem. 2006, 54:763-771.
16. Komohara Y., Ohnishi K., Kuratsu J., Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J. Pathol. 2008, 216:15-24.
17. Koning N., Uitdehaag B.M., Huitinga I., Hoek R.M. Restoring immune suppression in the multiple sclerosis brain. Prog. Neurobiol. 2009, 89:359-368.
18. Kristiansen M., Graversen J.H., Jacobsen C., Sonne O., Hoffman H.J., Law S.K., Moestrup S.K. Identification of the haemoglobin scavenger receptor. Nature 2001, 409:198-201.
19. Marik C., Felts P.A., Bauer J., Lassmann H., Smith K.J. Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?. Brain 2007, 130:2800-2815.
20. Marquet F., Bonneau M., Pascale F., Urien C., Kang C., Schwartz-Cornil I., Bertho N. Characterization of dendritic cells subpopulations in skin and afferent lymph in the swine model. PLoS One 2011, 6:e16320.
21. Nataf S. Neuroinflammation responses and neurodegeneration in multiple sclerosis. Rev. Neurol. (Paris) 2009, 165:1023-1028.
22. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 2010, 72:219-246.
23. Onofre G., Kolackova M., Jankovicova K., Krejsek J. Scavenger receptor CD163 and its biological functions. Acta Medica (Hradec Kralove) 2009, 52:57-61.
24. Philippidis P., Mason J.C., Evans B.J., Nadra I., Taylor K.M., Haskard D.O., Landis R.C. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ. Res. 2004, 94:119-126.
25. Prineas J.W., Wright R.G. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 1978, 38:409-421.
26. Raivich G., Banati R. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res. Brain Res. Rev. 2004, 46:261-281.
27. Ramagopalan S.V., Dobson R., Meier U.C., Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol. 2010, 9:727-739.
28. Roberts E.S., Masliah E., Fox H.S. CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE). J. Neuropathol. Exp. Neurol. 2004, 63:1255-1264.
29. Sanchez C., Domenech N., Vazquez J., Alonso F., Ezquerra A., Dominguez J. The porcine 2A10 antigen is homologous to human CD163 and related to macrophage differentiation. J. Immunol. 1999, 162:5230-5237.
30. Satoh J., Obayashi S., Misawa T., Tabunoki H., Yamamura T., Arima K., Konno H. Neuromyelitis optica/Devic's disease: gene expression profiling of brain lesions. Neuropathology 2008, 28:561-576.
31. Serafini B., Magliozzi R., Rosicarelli B., Reynolds R., Zheng T.S., Aloisi F. Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury. J. Neuropathol. Exp. Neurol. 2008, 67:1137-1148.
32. Steinman L. A molecular trio in relapse and remission in multiple sclerosis. Nat. Rev. Immunol. 2009, 9:440-447.
33. Topoll H.H., Zwadlo G., Lange D.E., Sorg C. Phenotypic dynamics of macrophage subpopulations during human experimental gingivitis. J. Periodontal Res. 1989, 24:106-112.
34. Tremlett H., Zhao Y., Rieckmann P., Hutchinson M. New perspectives in the natural history of multiple sclerosis. Neurology 2010, 74:2004-2015.
35. Van den Heuvel M.M., Tensen C.P., van As J.H., Van den Berg T.K., Fluitsma D.M., Dijkstra C.D., Dopp E.A., Droste A., Van Gaalen F.A., Sorg C., Hogger P., Beelen R.H. Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation. J. Leukoc. Biol. 1999, 66:858-866.
36. van der Valk P., De Groot C.J. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol. Appl. Neurobiol. 2000, 26:2-10.
37. Van Gorp H., Delputte P.L., Nauwynck H.J. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. Mol. Immunol. 2010, 47:1650-1660.
38. Zhang X., Winkles J.A., Gongora M.C., Polavarapu R., Michaelson J.S., Hahm K., Burkly L., Friedman M., Li X.J., Yepes M. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia. J. Cereb. Blood Flow Metab. 2007, 27:534-544.
39. Zhang Z., Schittenhelm J., Meyermann R., Schluesener H.J. Lesional accumulation of RhoA(+) cells in brains of experimental autoimmune encephalomyelitis and multiple sclerosis. Neuropathol. Appl. Neurobiol. 2008, 34:231-240.
40. Zwadlo G., Voegeli R., Osthoff K.S., Sorg C. A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process. Exp. Cell Biol. 1987, 55:295-304.